5.4(top 2%)
Impact Factor
5.9(top 2%)
extended IF
59(top 7%)
citing journals
citing authors

Most Cited Articles of Therapeutic Advances in Medical Oncology

An overview of the c-MET signaling pathway2011492
c-MET as a potential therapeutic target and biomarker in cancer2011261
Pharmacologic resistance in colorectal cancer: a review2016259
The PI3K/AKT/mTOR pathway in breast cancer: targets, trials and biomarkers2014251
Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management2010240
Targeting the Hedgehog pathway in cancer2010207
Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology2018202
Management of BRAF and MEK inhibitor toxicities in patients with metastatic melanoma2015192
Circulating tumour cells: their utility in cancer management and predicting outcomes2010174
Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy2016167
CDK4/6 inhibition in breast cancer: current practice and future directions2018167
Nivolumab in NSCLC: latest evidence and clinical potential2015164
Treatment options in recurrent ovarian cancer: latest evidence and clinical potential2014150
5-fluorouracil and cardiotoxicity: a review2018147
Predictive and prognostic molecular markers for cancer medicine2010138
Treatment of uveal melanoma: where are we now?2018136
Bone and brain metastasis in lung cancer: recent advances in therapeutic strategies2014135
HER2-positive breast cancer: new therapeutic frontiers and overcoming resistance2019129
Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients2018128
Health-related quality of life and cancer clinical trials2011127
Immunotherapeutic approaches in triple-negative breast cancer: latest research and clinical prospects2013121
Radiation effects on antitumor immune responses: current perspectives and challenges2018118
Cancer-induced muscle wasting: latest findings in prevention and treatment2017112
Nivolumab in melanoma: latest evidence and clinical potential2015108
Advanced pancreatic adenocarcinoma: a review of current treatment strategies and developing therapies2015104